Spots Global Cancer Trial Database for platelets
Every month we try and update this database with for platelets cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy | NCT00102726 | Thrombocytopaen... | SB497115 Placebo | 18 Years - | GlaxoSmithKline | |
Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia | NCT01286038 | Myelodysplastic... Thrombocytopeni... | Eltrombopag | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
Elevated Platelet Count as Prognostic Factor in Colorectal Cancer With Synchronous Liver Metastases | NCT03717519 | Colorectal Canc... Colorectal Carc... Stage IV Colon ... | Measurement of ... | 18 Years - 100 Years | Azienda Ospedaliera Universitaria Integrata Verona | |
Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer | NCT01148407 | Cancer | 18 Years - | University of Vermont | ||
AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin | NCT00147225 | Solid Tumors Advanced Cancer | AMG 531 Carboplatin Adriamycin Ifosfamide | 18 Years - | M.D. Anderson Cancer Center | |
AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin | NCT00147225 | Solid Tumors Advanced Cancer | AMG 531 Carboplatin Adriamycin Ifosfamide | 18 Years - | M.D. Anderson Cancer Center | |
Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia | NCT01286038 | Myelodysplastic... Thrombocytopeni... | Eltrombopag | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
The Importance of Inflammatory Markers Calculated From Preoperative and Postoperative Peripheral Blood Results in the Diagnosis and Treatment of Patients Operated for Hydatid Cyst of the Lung (Lung Echinococcus Granulosus) | NCT06281522 | Lung Hydatid Cy... | Operated patien... | 18 Years - 83 Years | Yuzuncu Yıl University | |
Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL) | NCT01168921 | CLL Leukemia | Eltrombopag | 18 Years - | M.D. Anderson Cancer Center | |
The Impact of Tamoxifen and Aromatase Inhibitors on Platelet Proteins | NCT01341171 | Breast Cancer | 18 Years - | University of Vermont | ||
Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy | NCT00187109 | Germ Cell Tumor... Hepatic Cancer Neuroblastoma Osteosarcoma Rhabdomyosarcom... | Recombinant Hum... | - 21 Years | St. Jude Children's Research Hospital | |
A Study of Effect of Megakaryocytes and Platelets in Breast Cancer | NCT06011824 | Breast Cancer | Blood draw | 18 Years - | Mayo Clinic | |
AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin | NCT00147225 | Solid Tumors Advanced Cancer | AMG 531 Carboplatin Adriamycin Ifosfamide | 18 Years - | M.D. Anderson Cancer Center | |
A Study of Effect of Megakaryocytes and Platelets in Breast Cancer | NCT06011824 | Breast Cancer | Blood draw | 18 Years - | Mayo Clinic | |
Development of Therapeutic Approaches Modulating Molecular Targets Implicated on Cancer Stem Cell-related Aggressiveness | NCT06348693 | Glioblastoma Glioma Glioma Glioblas... | cell isolation ... | 18 Years - | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | |
Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia | NCT01286038 | Myelodysplastic... Thrombocytopeni... | Eltrombopag | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute |